| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/1997 | EP0758233A1 Pde iv inhibitors for treating multiple sclerosis |
| 02/19/1997 | EP0758232A1 Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 02/19/1997 | EP0758231A1 Taxane class derivative based pharmaceutical compositions |
| 02/19/1997 | EP0758230A1 Use of estrone derivatives as steroid sulphatase inhibitors |
| 02/19/1997 | EP0758228A1 Effective dosage form for antiepileptic drugs |
| 02/19/1997 | EP0758226A1 Red blood cell surrogate |
| 02/19/1997 | EP0691843B1 Retarded-action microtablet made of beta-phenylpropiophenone derivatives |
| 02/19/1997 | EP0654026B1 Isoserine derivatives and their use as leukotriene antagonists |
| 02/19/1997 | EP0651751B1 Family of porphin ring substances, method of obtaining them from cyanophyceae, and applications as cosmetics and as therapeutic products |
| 02/19/1997 | EP0614362B1 Pharmaceutical compositions based on ebastine or analogues thereof |
| 02/19/1997 | EP0491878B1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/19/1997 | EP0485431B1 Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents |
| 02/19/1997 | CN1143388A Novel process for isolation of clavulanic acid and of pharmaceutically acceptable salts |
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1143379A Crosslinked polymeric ammonium salts |
| 02/19/1997 | CN1143367A 1,4-benzoxazine-2-acetic acid compound, process for producing the same and use thereof |
| 02/19/1997 | CN1143366A 4-amino derivatives of mycophenolic acid |
| 02/19/1997 | CN1143365A Phenyl-heterocycles as COX-2 inhibitors |
| 02/19/1997 | CN1143363A Isoxazoline compounds as inhibitors of TNF release |
| 02/19/1997 | CN1143358A Benzamide analogs, useful as parp (ADP-ribosyltransferase, ADRPT) DNA repair enzyme inhibitors |
| 02/19/1997 | CN1143356A Process for isomerizing linear olefins to isoolefins |
| 02/19/1997 | CN1143324A Novel pharmaceutical composition for skin diseases |
| 02/19/1997 | CN1143323A Bicyclic fibrinogen antagonists |
| 02/19/1997 | CN1143322A Pharmaceutical composition of indene derivatives for regulating apoptosis |
| 02/19/1997 | CN1143321A Treatment of obsessive-compulsive disorders with 5-HT2 antagonists |
| 02/19/1997 | CN1143320A Sublingual or buccal pharmaceutical composition |
| 02/19/1997 | CN1143319A Compound and methods for treatment of cardiovascular, inflammatory and immune disorders |
| 02/19/1997 | CN1143314A Drug-containing adhesive composite transdermal delivery device |
| 02/19/1997 | CN1143084A Anti-oxidant grafted polysaccharide and its use |
| 02/19/1997 | CN1143080A Method for preparing 7-bicyclic substituted -3-quinone derivative |
| 02/19/1997 | CN1143079A Benzo-iso-thiazolyl substituted amino methyl-benzodipyran |
| 02/19/1997 | CN1143076A 4-fluoroalkyl substituted phenacyl guanidine, its preparing method, application as medicine or diagnosis agent and medicine containing such compound |
| 02/19/1997 | CN1143075A 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 02/19/1997 | CN1142966A Making up method for medicinal liquid of ice guide therapeutic method on channels and acupuncture point |
| 02/19/1997 | CN1142947A Medicine for curing tooth ache |
| 02/19/1997 | CN1142946A Application of cucoline in preparing medicine for chronic nephritis |
| 02/19/1997 | CN1142945A Medcine for curing cerebrovascular disturbance with psychonosema |
| 02/19/1997 | CN1034077C Preparation of new pyrido|2,3-f¨|1,4¨ thiazepines |
| 02/19/1997 | CN1034075C Benzothiazepine derivatives |
| 02/19/1997 | CN1034074C Preparing method for heterocycle-substituted benzenemethanamine derivatives |
| 02/19/1997 | CN1034073C Process for substituted pyridyl-dihydroxy-heptenoic sodium salt |
| 02/19/1997 | CN1034072C Preparing method for tetrahydrocarbazole derivative |
| 02/19/1997 | CN1034054C Preparing method for improved oligosaccharide conjugate vaccines |
| 02/18/1997 | USRE35458 Reacting aqueous solution of copper nitrate and aqueous ethanolic solution of 4,7-diphenyl-1,10-phenanthroline under acidic conditions, adding aqueous solution of amino acid under alkaline conditions to obtain complex |
| 02/18/1997 | US5604263 Administering compounds extracted from hops to inhibit bone resorption |
| 02/18/1997 | US5604262 Topical antimicrobial agents |
| 02/18/1997 | US5604261 Having hydroxyl/alkoxyl group ortho to amide group on phenyl ring; high melatonin receptor affinity |
| 02/18/1997 | US5604260 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
| 02/18/1997 | US5604259 Adminstering for the treatment of osteoporosis |
| 02/18/1997 | US5604258 Methods for treating malaria and other diseases |
| 02/18/1997 | US5604257 Useful as an osteogenetic accelerator |
| 02/18/1997 | US5604256 Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition |
| 02/18/1997 | US5604252 Substance p antagonist |
| 02/18/1997 | US5604251 Hypotensive agents |
| 02/18/1997 | US5604248 Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| 02/18/1997 | US5604247 Chromone Derivatives |
| 02/18/1997 | US5604245 Use of 4-amino-1-(2-pyridyl)piperidines for the preparation of a medicament for the treatment of conditions deriving from disorders of the serotoninergic systems mediated by 5-HT3 receptors |
| 02/18/1997 | US5604244 Intraocular irrigating solution containing a polyamine antagonist |
| 02/18/1997 | US5604242 Alkoxy- and carboxy-substituted piperidines for suppressing uptake of gamma-aminobutyric acid, analgesics, anxiolytic or antiepileptic agents |
| 02/18/1997 | US5604239 Imidazopyridines as serotonergic 5-HT3 antagonists |
| 02/18/1997 | US5604237 Improve or increase efficacy of antitumor agent, increase or restore sensitivity of tumor to antitumor agent, reverse or reduce resistance of tumor to antitumor agent |
| 02/18/1997 | US5604236 Beta-carboline thromboxane synthase inhibitors |
| 02/18/1997 | US5604233 Water soluble antitumor, anticancer agent |
| 02/18/1997 | US5604231 Non-steroidal antiinflammatory agents, dopaminergic agents; side effect reduction |
| 02/18/1997 | US5604230 Useful in inhibiting the replication of hiv |
| 02/18/1997 | US5604228 Substituted guanidines having high binding to the sigma receptor and the use thereof |
| 02/18/1997 | US5604227 Excitatory amino acid antagonist; mono, di or tri-acetylation or alkylation |
| 02/18/1997 | US5604225 Dietetics; obesity |
| 02/18/1997 | US5604224 Substituted heterocyclylisoquinolinium salts and compositions and methods of use thereof |
| 02/18/1997 | US5604223 Treating epilepsy, nervous system disorder |
| 02/18/1997 | US5604221 Treating congestive heart failure, irritable bowel syndrome |
| 02/18/1997 | US5604218 Cephalosporin antibiotics |
| 02/18/1997 | US5604217 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for their preparation |
| 02/18/1997 | US5604216 Diluted mixtures for use as drugs or nutritional supplements |
| 02/18/1997 | US5604215 Sulfonated oestrone or dehydroepiandrosterone and derivatives; anti breast cancer agent |
| 02/18/1997 | US5604214 Administering a 4-ene-5-alpha-reductase inhibiting compound |
| 02/18/1997 | US5604212 Salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 02/18/1997 | US5604211 Saccharide for supplementing energy to living body, and uses |
| 02/18/1997 | US5604210 Inhibitor of vascular permeability enhancer |
| 02/18/1997 | US5604209 Combination of 6-benzyl-1-ethoxymethyl-5-isopropyluracil anddideoxyribonucleosides; treating human immunodeficiency virus |
| 02/18/1997 | US5604207 Sialyl Lex analogues as inhibitors of cellular adhesion |
| 02/18/1997 | US5604206 Complexes containing S(+) phenyl alkane acids and amino sugars |
| 02/18/1997 | US5604201 Methods and reagents for inhibiting furin endoprotease |
| 02/18/1997 | US5604199 Method of treating fibrosis in skeletal muscle tissue |
| 02/18/1997 | US5604182 Milbemycin ether derivatives, their preparation and their therapeutic and agrochemical uses |
| 02/18/1997 | US5604115 Liver enriched transcription factor |
| 02/18/1997 | US5604103 Kit for detection of clinical marker in kidney stone disease |
| 02/18/1997 | US5603959 Non-steroidal anti-inflammatory drug linked with unsaturated fatty acid or alcohol; cytoprotective agents, side effect reduction |
| 02/18/1997 | US5603957 Microcapsules for the controlled release of acetylsalicyclic acid in the gastrointestinal environment |
| 02/18/1997 | US5603954 Pentoxifylline therapy and method of use |
| 02/18/1997 | US5603949 Use of a tocopherol phosphate or one of its derivatives, for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
| 02/18/1997 | US5603947 Laminated composite comprising nicotine impermeable backing layer, matrix layer containing mixture of nicotine and polymer such that nicotine release is controlled by composite |
| 02/18/1997 | US5603945 Therapeutic/prophylactic agents and method of treating for urinary calculosis in pets |
| 02/18/1997 | US5603930 Lactobacillus johnsonii CNCM I-1225 |
| 02/18/1997 | US5603918 Mixture with soya protein as a suspending agent and propellant |
| 02/17/1997 | CA2183469A1 New cephalosporins containing a substituted benzyloxyimino radical in position 7; process and intermediates for preparing them and use thereof as therapeutic agents |
| 02/17/1997 | CA2183307A1 Endothelin receptor antagonists |
| 02/17/1997 | CA2183015A1 Composition and method for treating prostate cancer |
| 02/16/1997 | CA2182851A1 Method for treating substance abuse withdrawal |
| 02/15/1997 | CA2183208A1 Antidepressant 1-arylalkyl-4-(alkoxypyridinyl)-or 4-(alkoxypyrimidinyl) piperazine derivatives |